Squeeze Report — July 31, 2026
A bifurcated day for squeeze candidates: biotech pre-earnings plays (CRVS, IMVT, SNDX) show coiled springs with tight borrow and near-term catalysts, while heavily-shorted tech names (TEM, CRSR) are undermined by cheap borrow, declining short interest, and fundamental decay. The market’s rotation into healthcare is providing a tailwind for the right setups, but the wrong ones—like AESI and FMC—are value traps, not squeeze plays.
Today's top short-squeeze candidates
- #1AVTXAvalo Therapeutics, Inc. Commo86
117% of float sold short · 10.7 days to cover · +12% over 20 days · options pricing in the 81th percentile (crowded)
SI 117%DTC 10.7$19.39+12% 20dHealthcare - #2TMDXTransMedics Group, Inc. Common80
23% of float sold short · 9.5 days to cover · +12% over 20 days
SI 23%DTC 9.5$76.13+12% 20dHealthcare - #3GRPNGroupon, Inc. Common Stock80
67% of float sold short · 9.1 days to cover · +9% over 20 days
SI 67%DTC 9.1$27.89+9% 20dCommunication Services - #4NTSTNetSTREIT Corp.80
33% of float sold short · 22.2 days to cover · +2% over 20 days
SI 33%DTC 22.2$21.59+2% 20dReal Estate - #5ITGartner, Inc.79
18% of float sold short · 9.0 days to cover · +14% over 20 days
SI 18%DTC 9.0$152.92+14% 20dIndustrials - #6CERTCertara, Inc. Common Stock79
28% of float sold short · 7.8 days to cover · +16% over 20 days · options pricing in the 83th percentile (crowded)
SI 28%DTC 7.8$7.78+16% 20dHealthcare - #7CRSRCorsair Gaming, Inc. Common St76
Elevated 23% short interest and insider buying ahead of Aug 6 earnings are offset by a $300M shelf and a sector rotation away from tech.
SI 23%DTC 8.3$10.63+12% 20dTechnology - #8CHTRCharter Communications, Inc. C76
26% of float sold short · 9.4 days to cover · +2% over 20 days
SI 26%DTC 9.4$142.00+2% 20dCommunication Services - #9LQDALiquidia Corporation Common St75
The 19.8% short interest and 9.2 days to cover hinge entirely on a binary patent ruling; aggressive insider selling at these highs is a glaring red flag.
SI 20%DTC 9.2$86.80+9% 20dHealthcare - #10OLMAOlema Pharmaceuticals, Inc. Co75
21% of float sold short · 11.3 days to cover · -2% over 20 days
SI 21%DTC 11.3$11.82-2% 20dHealthcare - #11IBRXImmunityBio, Inc. Common Stock75
118% of float sold short · 11.9 days to cover · -19% over 20 days
SI 118%DTC 11.9$7.45-19% 20dHealthcare - #12ASANAsana, Inc. Class A Common Sto74
39% of float sold short · 6.8 days to cover · +9% over 20 days
SI 39%DTC 6.8$7.95+9% 20dTechnology - #13CRVSCorvus Pharmaceuticals, Inc. C74
Tight borrow, 12.6 days to cover, and insider buying ahead of Q2 earnings make this a coiled spring, though a $200M ATM shelf is the safety valve for shorts.
SI 25%DTC 12.6$13.19-11% 20dHealthcare - #14TNDMTandem Diabetes Care, Inc. Com74
21% of float sold short · 8.7 days to cover · +21% over 20 days
SI 21%DTC 8.7$19.01+21% 20dHealthcare - #15PGENPrecigen, Inc. Common Stock74
A 25.8% short interest and pre-earnings rally look tempting, but declining short interest and 1.4% options IV suggest the squeeze already happened.
SI 26%DTC 9.6$5.94+13% 20dHealthcare
See the full ranked board
This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.
Open the live squeeze board →